Merck (MRK) Tops Q2 EPS by 14c, Beats on Revenue; Offers FY26 EPS Guidance

August 4, 2026 6:33 AM EDT

Merck (NYSE: MRK) reported Q2 EPS of ($0.13), $0.14 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.41 billion.

GUIDANCE:

Merck sees FY2026 EPS of $2.66-$2.76, versus the consensus of $2.76.

For earnings history and earnings-related data on Merck (MRK) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK